vs
BillionToOne, Inc.（BLLN）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
BillionToOne, Inc.的季度营收约是RMR GROUP INC.的1.3倍（$83.5M vs $66.7M），RMR GROUP INC.净利率更高（18.3% vs 6.8%，领先11.4%），BillionToOne, Inc.同比增速更快（117.4% vs 40.8%）
BillionToOne, Inc.是一家生命科学与分子诊断企业，专注研发高精度基因检测解决方案，核心产品包括无创产前检测、肿瘤诊断试剂及罕见病筛查服务，服务全球多地的医疗机构、患者及科研合作方。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
BLLN vs RMR — 直观对比
营收规模更大
BLLN
是对方的1.3倍
$66.7M
营收增速更快
BLLN
高出76.6%
40.8%
净利率更高
RMR
高出11.4%
6.8%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $83.5M | $66.7M |
| 净利润 | $5.7M | $12.2M |
| 毛利率 | 69.9% | — |
| 营业利润率 | 11.5% | 48.1% |
| 净利率 | 6.8% | 18.3% |
| 营收同比 | 117.4% | 40.8% |
| 净利润同比 | 138.3% | 91.1% |
| 每股收益（稀释后） | $0.10 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLLNRMR
| Q4 25 | — | $66.7M | ||
| Q3 25 | $83.5M | — | ||
| Q3 24 | $38.4M | — |
净利润BLLNRMR
| Q4 25 | — | $12.2M | ||
| Q3 25 | $5.7M | — | ||
| Q3 24 | $-14.9M | — |
毛利率BLLNRMR
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q3 24 | 52.6% | — |
营业利润率BLLNRMR
| Q4 25 | — | 48.1% | ||
| Q3 25 | 11.5% | — | ||
| Q3 24 | -32.9% | — |
净利率BLLNRMR
| Q4 25 | — | 18.3% | ||
| Q3 25 | 6.8% | — | ||
| Q3 24 | -38.8% | — |
每股收益（稀释后）BLLNRMR
| Q4 25 | — | $0.71 | ||
| Q3 25 | $0.10 | — | ||
| Q3 24 | $-1.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.2M | $49.3M |
| 总债务越低越好 | $55.0M | — |
| 股东权益账面价值 | $-239.5M | $232.7M |
| 总资产 | $327.5M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BLLNRMR
| Q4 25 | — | $49.3M | ||
| Q3 25 | $195.2M | — | ||
| Q3 24 | — | — |
总债务BLLNRMR
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q3 24 | — | — |
股东权益BLLNRMR
| Q4 25 | — | $232.7M | ||
| Q3 25 | $-239.5M | — | ||
| Q3 24 | $-242.9M | — |
总资产BLLNRMR
| Q4 25 | — | $687.1M | ||
| Q3 25 | $327.5M | — | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.8M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $6.5M | — |
| 自由现金流率自由现金流/营收 | 7.7% | — |
| 资本支出强度资本支出/营收 | 8.8% | — |
| 现金转化率经营现金流/净利润 | 2.42× | 0.88× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BLLNRMR
| Q4 25 | — | $10.7M | ||
| Q3 25 | $13.8M | — | ||
| Q3 24 | — | — |
自由现金流BLLNRMR
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q3 24 | — | — |
自由现金流率BLLNRMR
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q3 24 | — | — |
资本支出强度BLLNRMR
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q3 24 | — | — |
现金转化率BLLNRMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | 2.42× | — | ||
| Q3 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
